Key Message {#sec1}
===========

Limited access to opioids for patients with cancer has been reported as a potential unintended consequence of recent regulations restricting opioid use and prescribing practices. After receiving outpatient supportive care, approximately one-third of cancer patients with an opioid prescription perceived having difficulties when filling their opioid prescription.

Introduction {#sec2}
============

Pain is one of the most frequent and burdensome symptoms among patients with cancer, with prevalence rates of 66% in patients with metastatic disease, 55% in patients during treatment, and 39% in patients after curative treatment.[@bib1] Although opioid therapy remains the first line of defense for effective management of cancer-related pain,[@bib2] the abuse and misuse of opioids continues to be a growing epidemic in the U.S.[@bib3] Subsequently, the Centers for Disease Control and Prevention, released guidelines for physicians to safely prescribe opioids to patients.[@bib4] Although these guidelines exclude patients undergoing active cancer treatment or palliative care, recent reports show that an unintended consequence of the systemic and regulatory changes has been limited access to opioids for patients with cancer.[@bib5], [@bib6], [@bib7], [@bib8] In a survey conducted by Public Opinion Strategies on behalf of the American Cancer Society Cancer Action Network and the Patient Quality of Life Coalition, cancer patients, survivors, and others with serious illnesses reported having experienced increased difficulties receiving their opioid prescription from 2016 to 2018.[@bib9] This limited access to opioids adversely impacts the management of cancer-related pain, as at least one-third of patients with cancer reported that they did not receive adequate medication for the intensity of their pain.[@bib10], [@bib11], [@bib12] The under-treatment of cancer pain is associated with other psychosocial and physical symptoms that negatively affect clinical outcomes and the patient\'s quality of life.[@bib9] ^,^ [@bib13]

Barriers that prevent adequate pain management for patients with cancer have been previously described, including regulatory requirements, racial and socioeconomic disparities, societal attitudes toward pain management (i.e., opioid stigma),[@bib14] and parenteral opioid shortages.[@bib15], [@bib16], [@bib17] The availability of opioids has been further impacted by the reduction in opioid prescription patterns among oncologists. One study reported a significant decreasing annual trend of opioid use in patients with advanced cancer who received inpatient palliative care (morphine equivalent daily dose of 150 mg/day in 2008 to 83 mg/day in 2014).[@bib18] Another study showed that the amount of opioids prescribed to patients with cancer before referral to an outpatient palliative care clinic decreased to 40 mg/day in 2015 from 78 mg/day in 2010.[@bib19] Moreover, anecdotal patient reports to our clinic describing difficulties in filling opioid prescriptions make us suspicious that this may be a widespread problem.

Although the impact of the opioid epidemic and the recent regulatory changes on cancer patients\' access to their opioid medications has been described,[@bib15] ^,^ [@bib16] ^,^ [@bib18] ^,^ [@bib19] there are a limited number of peer-reviewed studies that have evaluated cancer patients\' perceived difficulties when filling their opioid prescriptions. Based on the previous limited literature, we hypothesized that after receiving outpatient supportive care, cancer patients perceive difficulties when filling their opioid prescription. Therefore, this pilot study was conducted to determine cancer patients\' perceived difficulties when filling their opioid prescription after receiving outpatient supportive care. To understand these difficulties, we conducted a patient survey with questions about the patient\'s experiences in filling their opioid prescriptions. The patients also answered questions about their experiences filling prescriptions for their other regular (nonopioid) medications. Knowledge and understanding of these perceived difficulties will shed light on the contributors of these issues and allow for implementation of strategies to overcome the difficulties to ensure that patients with cancer are not negatively impacted when obtaining their legitimate opioid prescriptions.

Methods {#sec3}
=======

This survey study was approved by the Institutional Review Board at The University of Texas MD Anderson Cancer Center. Patients were eligible to participate if they were at least of 18 years, had a cancer diagnosis, were receiving opioids prescribed by the MD Anderson supportive care center (SCC), had visited the SCC two previous times for the purpose of opioid pain management, and were able to understand, read, write, and speak English. The survey consisted of 24 questions relating to patients\' perceptions of the problems that they encountered when filling their prescriptions for opioids. To our knowledge, there are no validated measurements to use for evaluation of patients\' difficulties filling opioid prescriptions. The survey was developed based on a previous study conducted by Public Opinion Strategies on behalf of the American Cancer Society Cancer Action Network and the Patient Quality of Life Coalition,[@bib9] and questions used in the survey were refined by input from experts in the field at MD Anderson SCC. The survey was assessed for readability and was pilot-tested on volunteers to ensure that it took less than 10 minutes to complete. Five minutes was the average time to complete the survey. Before administration of the survey, patients\' demographic and clinical information were collected, including scores on the Cut-down, Annoyed, Guilty, and Eye-opener questionnaire, opioid prescription history, and cancer diagnosis.

Our primary objective was to evaluate cancer patients\' perceptions of overall difficulties when filling their opioid prescription. Overall difficulty was determined by a yes and/or no question on the survey. Our secondary objectives were to determine if associations existed between patient characteristics and patient difficulty filling opioid prescriptions, and to evaluate the patients\' perceived difficulties when filling opioid vs. nonopioid prescriptions.

Statistical Analysis {#sec3.1}
--------------------

Summary statistics were used to describe the demographic and clinical characteristics of the study population. The association between patients\' perception about difficulty filling opioids and their characteristics was evaluated by Wilcoxon rank sum test and Chi-squared (Fisher\'s exact) test for continuous and categorical variables, respectively. Estimates of odds ratio along with 95% CI were calculated by fitting univariate logistic models.

Results {#sec4}
=======

A total of 962 patients with advanced cancer presenting to the MD Anderson SCC were screened between April and September 2019. Of the 238 patients who were eligible, 156 patients were approached and 140 patients completed the survey ([Fig. 1](#fig1){ref-type="fig"} ). The reasons for not approaching 82 of the 238 eligible patients are listed in [Fig. 1](#fig1){ref-type="fig"}. One patient who completed the survey only received prescriptions via mail order, so that patient\'s responses were removed from the analysis. [Table 1](#tbl1){ref-type="table"} lists the demographic and clinical characteristics of 139 patients who completed the survey. The median age (interquartile range) was 60 (20, 90) years, and 55% of the patients were female.Fig. 1Consolidated Standards of Reporting Trials diagram of patients\' flow throughout the study. SCC = supportive care center; MDAS = Memorial Delirium Assessment Scale; MD = medical doctor; RN = registered nurse.Table 1Patient CharacteristicsVariableTotal, *n* (%)Overall, Has the Patient Had Difficulties When Filling Their Opioid Prescription? *n* (%)[a](#tbl1fna){ref-type="table-fn"}YesNoAll patients139 (100)44 (32)95 (68)Median age (range)60 (20, 90)59 (20, 81)62 (30, 90)Female sex76 (55)25 (57)51 (54)Race/ethnicity White96 (69)33 (75)63 (66) African American28 (20)7 (16)21 (22) Hispanic13 (10)2 (4.5)11 (12) Asian/Pacific Islander2 (1)2 (4.5)0Marital status Married/significant other92 (66)25 (57)67 (71) Single18 (13)8 (18)10 (11) Divorced16 (12)7 (16)9 (9) Widowed/separated13 (9)4 (9)9 (9)Highest level of education completed Less than high school/tech school12 (9)4 (9)8 (8) High school/tech school30 (22)6 (14)24 (25) Incomplete college or junior college38 (27)12 (27)26 (27) Complete college39 (28)16 (36)23 (24) Incomplete masters/doctoral degree3 (2)03 (3) Complete masters/doctoral degree17 (12)6 (14)11 (12)Annual household income \<\$40,00038 (28)13 (30)25 (27) \$40,000--\$80,00033 (24)11 (24)22 (23) \>\$80,00036 (26)13 (30)23 (24) Prefer not to say31 (22)7 (16)25 (26)Cancer diagnosis Breast21 (15)9 (21)12 (13) Gastrointestinal23 (17)8 (18)15 (16) Head and neck18 (13)6 (14)12 (13) Genitourinary20 (14)5 (11)15 (16) Gynecologic13 (9)5 (11)8 (8) Thoracic23 (17)5 (11)18 (19) Sarcoma9 (7)3 (7)6 (6) Other[b](#tbl1fnb){ref-type="table-fn"}12 (8)3 (7)9 (9)Current cancer stage Locally advanced38 (27)10 (23)28 (30) Metastatic101 (73)34 (77)67 (70)CAGE-AID positive22 (16)8 (18)14 (15)First given opioids (months) Less than three11 (8)5 (11)6 (6) Three to six22 (16)5 (11)17 (18) Six to 1242 (30)12 (27)30 (32) \>1264 (46)22 (50)42 (44)Median MEDD (IQR)120 (80, 185)151 (82, 242)120 (80, 180)[^1][^2][^3]

[Table 2](#tbl2){ref-type="table"} reports the perceived experiences of patients when filling their opioid prescription. Overall, 44 patients (32%) reported that they have experienced difficulty filling their opioid prescription. Of those 44 patients, 12 (27%) said that the pharmacist(s) remembers them each time, which is significantly lower than the 55% of patients (53 of 96) who have not experienced difficulty and also said that the pharmacist remembers them (*P* \< 0.005). [Table 3](#tbl3){ref-type="table"} reports the attitudes and beliefs of patients according to difficulty filling their opioid prescription. Those who reported difficulty filling their opioid prescription were more likely to feel emotional distress when going to the pharmacy (12 of 44 \[27%\] vs. 3 of 95 \[3%\]; *P* \< 0.001), that the difficulty was caused by the pharmacy and/or pharmacist (12 of 44 \[27%\] vs. 1 of 95 \[1%\]; *P* \< 0.001), and that the pharmacist makes them feel ashamed (6 of 44 \[14%\] vs. 0 of 95 \[0%\]; *P* \< 0.001).Table 2Perceived Difficulties Experienced by Patients When Filling Opioid PrescriptionsVariableTotal, *n* (%)[a](#tbl2fna){ref-type="table-fn"}Overall, Has the Patient Had Difficulties When Filling Their Opioid Prescription? *n* (%)[a](#tbl2fna){ref-type="table-fn"}*P*YesNoAll patients139 (100)44 (32)95 (68)Do you regularly receive your opioid prescription from the same pharmacist(s)?[b](#tbl2fnb){ref-type="table-fn"}115 (83)33 (75)82 (85)0.072Does the pharmacist seem to remember you each time you visit the pharmacy?[b](#tbl2fnb){ref-type="table-fn"}65 (48)12 (27)53 (55)0.005How often have you been unable to get your opioid prescription?5 (4)4 (9)1 (1)0.035How often have you been unable to get your opioid prescription because the pharmacy did not have the particular drug in stock?7 (5)4 (9)3 (3)0.207How often have you been unable to get your opioid prescription because your insurance would not cover it?2 (1)2 (5)0 (0)0.098How often has a pharmacist asked you about why you needed your opioid prescription?4 (3)3 (7)1 (1)0.094How often has your insurance company limited you to only one pharmacy to go to for filling your opioid prescription?3 (2)0 (0)3 (3)0.551How often has your insurance company reduced the number of times you can refill your opioid prescription?3 (203 (7)0 (0)0.031How often has your insurance company reduced the number of pills in your opioid prescription?3 (2)3 (7)0 (0)0.032How often has the pharmacist given you only part of your opioid prescription (e.g., for seven days instead of the 30 days for which the prescription was written)?3 (2)3 (7)0 (0)0.030How often have you paid a high copay (more than \$50) for your opioid prescription?10 (7)4 (9)6 (63)0.726[^4][^5]Table 3Attitudes and Beliefs of Patients Who Report Difficulty Filling Their Opioid PrescriptionVariableTotal, *n* (%)[a](#tbl3fna){ref-type="table-fn"}Overall, Has Patient Had Difficulties When Filling Their Opioid Prescription? *n* (%)[a](#tbl3fna){ref-type="table-fn"}*P*YesNoAll patients139 (100)44 (32)95 (68)I feel financial distress when filling my opioid prescription18 (13)6 (14)12 (13)1.00I feel that the pharmacy/pharmacist makes the process of filling my opioid prescription difficult13 (9)12 (27)1 (1)\<0.001I feel emotional distress when I go to the pharmacy to fill my opioid prescription15 (11)12 (27)3 (3)\<0.001The pharmacist makes me feel ashamed for having an opioid prescription6 (4)6 (14)0 (0)\<0.001I feel more comfortable filling my opioid prescription at a pharmacy in a different neighborhood than where I live11 (8)5 (11)6 (6)0.324Overall, it is more difficult to fill my opioid prescription than to fill my other nonopioid prescription medicine(s)46 (33)30 (68)16 (17)\<0.001I feel more financial distress when filling my opioid prescription than when filling my other nonopioid prescription medicine(s)19 (14)11 (25)8 (8)0.015I feel that the pharmacy/pharmacist makes the process more complicated when I fill my opioid prescription than when I fill my other nonopioid prescription medicine(s)20 (14)17 (39)3 (3)\<0.001I feel more emotional distress at the pharmacy when I pick up my opioid prescription than when I pick up my other nonopioid prescription medicine(s)9 (7)7 (16)2 (2)0.005The pharmacist treats me differently when I pick up my opioid prescription than when I pick up my other nonopioid prescription medicine(s)7 (5)5 (11)2 (2)0.033[^6]

Difficulty filling opioid prescriptions as compared with nonopioid prescriptions was reported more frequently among the 44 patients who perceived overall difficulty filling their opioid prescription (30 of 44 \[68%\] vs. 16 of 95 \[17%\]; *P* \< 0.001). We asked patients to report the most common reason they had difficulty filling their opioid prescription vs. their nonopioid prescription. Consistent with patients with difficulty indicating the pharmacist as the reason for their difficulty, 17 of 44 patients (39%) also identified the pharmacy and/or pharmacist as the most common reason. The other most common reasons for difficulty filling their opioid vs. nonopioid prescriptions included financial distress (11 patients; 25%) and emotional distress (7 patients; 16%) when picking up their opioid prescription. The mean morphine equivalent daily dose was statistically significantly greater in patients who reported more difficulty filling their opioid prescription than their nonopioid prescription (217 mg/day vs. 137 mg/day; *P* \< 0.001). There was no association between reported difficulty and the patients\' demographic characteristics.

Discussion {#sec5}
==========

The results of this pilot study show that patients with cancer who are on opioid therapy to manage their pain have perceived having difficulties when filling their opioid prescriptions. Importantly, patients who reported difficulties were able to identify barriers related to psychological difficulties and the pharmacist\'s attitude toward them. The findings also show that patients perceived that it was more difficult to fill opioid prescriptions compared with nonopioid prescriptions. Overall, these results provide preliminary data on cancer patients\' perceptions of the difficulties encountered when trying to get their opioid prescription after visiting an outpatient SCC.

Our results are similar to another study conducted in adult cancer outpatients at a supportive care clinic that reports opioid stigma was endorsed by 59 of 97 (61%) patients who were prescribed opioids.[@bib20] When queried about specific aspects of opioid stigma that they experienced, 21 of 97 (22%) patients identified trouble filling prescriptions and 14 of 97 (14%) patients reported difficulty getting prescriptions.[@bib20] Our findings further suggest that the reason for difficulty in obtaining opioid prescriptions stems from emotional distress, most likely experienced from the interaction of the patient with the pharmacist when picking up their medication. Unlike other studies that report socioeconomic[@bib21] and racial[@bib22], [@bib23], [@bib24] disparities as a barrier to opioid access in general patient populations, this study did not show an association between patients\' racial demographics and difficulty obtaining opioids. One reason for this could be that most patients who completed the survey were white (69%). However, a large percentage of the patients who reported difficulty were white (75%), suggesting that limited opioid access may affect people across various racial groups. More research is needed to fully characterize the patient demographics associated with difficulty getting opioid prescriptions in the adult cancer population.

We were surprised to find that patients did not perceive having logistical difficulty, such as restrictions from the insurance company, when filling their opioid prescription. Although these challenges have been reported previously by others, it is possible that by the time this study was carried out, the opioid access difficulties originating from prior authorizations of insurance companies had been mostly resolved. Another possible explanation is that many patients might not understand that the barrier might stem from insurance issues and therefore ascribe their difficulty to the pharmacy and/or pharmacist. Nonetheless, it is possible that the current coronavirus disease 2019 (COVID-19) pandemic may cause new logistical difficulties, as the medical product chains are impacted by shortages in medications and patients across diagnoses are facing increasing difficulties seeking medical care;[@bib25] this makes it even more crucial that patients with cancer have access to their opioid prescriptions.

Some limitations of this study include its small sample size and the lack of a validated tool to assess patients\' perceptions of the difficulties encountered when filling their opioid prescription. Although patients\' demographic and clinical information was obtained, the geographic location of the pharmacy where the patient had difficulties was not collected because of concerns over patient privacy and zip code as potentially identifying information; thus, we were unable to assess if certain geographic regions were associated with difficulty filling opioid prescriptions. Because reports suggest that geographic factors could play a role in opioid access for patients,[@bib26] future studies overcoming privacy concerns around patient geography could prove extremely insightful. Another limitation is that the results might not be generalizable to patients receiving cancer care at other institutions and hospitals because this study was carried out at a single institution: a comprehensive cancer center with its own outpatient pharmacy. Moreover, the patients in this study were seen twice by our supportive care clinicians, who take extra care to ensure that patients have access to opioids for their pain by prescribing opioids that are less expensive. This scenario could be different in other clinics where financial concerns are not considered or in clinics that are not as experienced with strategies to overcome access barriers as in the SCC, suggesting that patients\' financial distress could be underrepresented. Finally, our results may not be generalizable to the overall U.S. cancer patient population, as the opioid epidemic has been characterized as less severe in Texas compared with other regions of the country.[@bib27]

Despite the limitations of the study, these findings suggest that negative interactions with pharmacists contribute to cancer patients\' perceived difficulties when obtaining their legitimate opioid medications. These interactions that inflict shame and emotional distress on the patient with cancer can lead to negative outcomes via avoidance of pharmacies and health care providers, poor adherence to pain medication, and undertreatment of pain.[@bib20] These findings further suggest opportunities to educate pharmacists on the experience of patients and their potential distress when filling their legitimate opioid prescriptions, along with educational opportunities to provide to patients in terms of their safe use of opioids and their rights when filling prescriptions. A study in our SCC showed that education focused on opioid safety for patients with advanced cancer led to improved patient-reported safe opioid storage, usage, and disposal.[@bib28] Providing this type of opioid management education for patients at the time of prescribing (by the physician) and at the time of dispensing (by the pharmacist) could reduce the patient\'s emotional distress by alleviating their concerns about using opioids as well as decreasing potential complications around filling the prescription from the pharmacist. Evaluating the use of educational material for patients and pharmacists when receiving and filling an opioid prescription would therefore be a rich avenue of future research.

The tantalizing results of this study suggest that additional research could uncover other contributors of perceived difficulty to accessing opioids in the context of the cancer patient population. To accomplish this effort, studies should be carried out to investigate the types of pharmacies where these difficulties are taking place (i.e., community pharmacies vs. hospital pharmacies). Importantly, additional studies are needed to determine the sociodemographic and clinical characteristics of patients who perceive difficulties when filling their opioid prescriptions.

Conclusions {#sec6}
===========

Evidence from this study shows that patients with cancer perceived difficulties when filling their opioid prescriptions, and the results suggest that negative interactions with the pharmacy and/or pharmacist contribute to their perceived difficulty. To ensure that patients with cancer can access their legitimate opioid prescriptions without negative impacts, including shame and emotional distress, further research efforts are needed to fully characterize these difficulties and to implement strategies that address their origins.
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[^1]: CAGE-AID = Cut Down, Annoyed, Guilty, Eye-opener Adapted to Include Drugs questionnaire; MEDD = morphine equivalent daily dose; IQR = interquartile range.

[^2]: Number and percentage of individuals reported are those who answered always/very often/sometimes to the stated variable.

[^3]: Other diagnoses include skin, lymphoma, myeloma, and leukemia.

[^4]: Number and percentage of individuals reported are those who answered always/very often/sometimes to the stated variable.

[^5]: Number and percentage of individuals reported are those who answered yes to the stated variable.

[^6]: Number and percentage of individuals reported are those who strongly agree/agree with the stated variable.
